The prevailing view is that in most cases (approximately 75%-80%), GIST pathogenesis is attributed to activating mutations in KIT or PDGFRA, genes encoding transmembrane tyrosine kinase receptors. Here, PDGFRA is linked to gastrointestinal stromal tumor.